Caradigm Sale – The Final Step in GE’s Exit From PHM/Value-based Care?
Published: July 3, 2018
03rd July 2018 – Featured in HIT Consultant – On 13th June 2018, cancer informatics and digital pathology workflow vendor, Inspirata, announced that it was purchasing GE Healthcare’s remaining population health management (PHM) interest, Caradigm. This follows the announcement in April 2018 that GE Healthcare was selling its ambulatory value-based care business to Veritas Capital. This latest announcement now means that GE Healthcare has exited the population health management market from both an enterprise and ambulatory perspective. It also means Caradigm is now for the first time cut free from GE
Here’s the Signify View on what this means for GE and CaradigmShare on LinkedIn
Population Health Management – North America – 2018June 2018
Population Health Management – North America – 2018
Signify Research’s 2018 North American PHM report provides a complete refresh of the market data to show how the market has progressed over the last 12 months. Purchasers also receive a mid-year update report.
Find out more